Author

Abdullah Altulea

University Medical Center GroningenORCID 0000-0001-6138-6486Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:development & morphogenesis· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Abel Soto-GameziD· 1 shared Boshi WangiD· 1 shared Caterina GianniiD· 1 shared Jamil NehmeiD· 1 shared Marco DemariaiD· 1 shared Michele ZanoniiD· 1 shared Sara BravacciniiD· 1 shared Sjors MaasseniD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abel Soto-GamezORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyThe EMBO JournalPeer-reviewedFeb 10, 2025

Pharmacological CDK4/6 inhibitors promote senescence-associated lysosomal alterations and enhance sensitivity to lysosomotropic agents in breast cancer

Jamil Nehme, Sjors Maassen, Sara Bravaccini…·Marco Demaria

This study shows CDK4/6 inhibitors induce senescence-like changes in breast cancer cells, increasing their sensitivity to lysosomotropic agents, and suggests sequential treatment could improve therapy efficacy.

19 citationstop 2%

humanbulk RNA-seq

𝕏 PostBluesky